Northpond Ventures

Portfolio Co Investors 2026 for Northpond Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Northpond Ventures accounts for 33 tracked companies with verified cap-table data, 33 of which disclose round sizes totalling $3.8B. The median disclosed raise is $70M, and the largest is DNAnexus at $473M, ahead of Delfi Diagnostics ($400M) and Vigil Neuroscience ($350M).

The names that recur most often on these co-invested cap tables are Northpond Ventures (33 companies), Khosla Ventures (4 companies), GV (3 companies), Illumina Ventures (3 companies), Alexandria Venture Investments (3 companies), Section 32 (3 companies). By latest disclosed round, the market skews Series A (13), Series B (7), Series C (3), IPO (2).

Best funded Northpond Ventures companies

  1. DNAnexus — $473M (latest: Series H)
  2. Delfi Diagnostics — $400M (latest: Series B)
  3. Vigil Neuroscience — $350M (latest: IPO)
  4. Scipher Medicine — $225M (latest: Series A)
  5. Syapse — $223M (latest: Series G)
  6. Inflammatix — $200M
  7. Initial Therapeutics — $187M (latest: IPO)
  8. Kyverna Therapeutics — $170M (latest: Series B)
  9. Sound Agriculture — $150M (latest: Growth)
  10. Sherlock Biosciences — $111M (latest: Series B)
  11. Mestag Therapeutics — $95M (latest: Seed)
  12. Ansa Biotechnologies — $86M (latest: Series A)
  13. Code Biotherapeutics — $85M (latest: Series A)
  14. StrideBio — $82M (latest: Series B)
  15. Encodia — $76M (latest: Series C)

Northpond Ventures, LLC — related firms and companies (56)

Northpond Ventures, LLC profile · All research reports